DFP Healthcare Price, Forecast, Insider, Ratings, Fundamentals & Signals

Cerritos, calif.--(business wire)--the oncology institute (toi) is proud to announce that dr. john khoury was recently awarded the “40 under 40 in cancer” award by the association for value-based cancer care. this is the second year in a row a toi physician was recognized for this honor. dr. omkar marathe was selected for the distinction in 2020. "it’s an honor to be part of such a distinguished list of young oncology professionals and leaders who work very hard to improve the lives of those affected by cancer," said dr. khoury. dr. john khoury is a triple board-certified physician who joined the oncology institute in 2020. he completed his residency and fellowship at oakland university william beaumont school of medicine in detroit, where he specialized in hematology and oncology...

New york--(business wire)--dfp healthcare acquisitions corp. (“dfp”) (nasdaq: dfph) announced today that it has scheduled the special meeting of its stockholders (the “special meeting”) for november 12, 2021 at 10:00 a.m., eastern time, to approve the proposed business combination (the “business combination”) with the oncology institute (“toi” or the “company”), the u.s. market leader in providing value-based oncology care. dfp also announced that it has filed its definitive proxy statement/prospectus for the special meeting and has commenced mailing the definitive proxy statement/prospectus to its stockholders of record as of september 23, 2021, the record date for the special meeting (the "record date")...

New york & los angeles--(business wire)--dfp healthcare acquisitions corp (“dfp”) (nasdaq: dfph, dfphw), a special purpose acquisition company sponsored by an affiliate of deerfield management company, l.p. (“deerfield”) and richard barasch, a veteran healthcare public company executive and investor, announced today that it has entered into a definitive agreement for a business combination with the oncology institute ( “toi” or “the company”), the u.s. market leader in providing value-based oncology care. following the business combination, dfp expects to be renamed the oncology institute and will remain listed on the nasdaq stock market under new ticker symbol “toi”. the oncology institute investment highlights leading value-based care provider in oncology – a huge addressable market: the oncology institute is leading the shift to value-based oncology care by utilizing a highly scalable and replicable operating model to disrupt the $200 billion u...

Stocks Analysis by Contrarian Outlook (Brett Owens) covering: United States 10-Year, Nuveen AMT Free Municipal Credit Income, iShares Floating Rate Bond ETF, iShares iBoxx $ High Yield Corporate Bond ETF. Read Contrarian Outlook (Brett Owens)'s latest article on Investing.com

This week has seen the SPAC boom shift into overdrive, with a flood of merger and initial public offering announcements. U) made its debut on the New York Stock Exchange on Monday, selling 11.5 million units at $10 with each consisting of one common share and half of a warrant exercisable at $11.50 a share. Total proceeds were $115 million, which includes underwriters’ overallotment option of 1.5 million units.